Looking At Merck & Co., Inc. (NYSE:MRK) From All Angles

Attractive stocks have exceptional fundamentals. In the case of Merck & Co., Inc. (NYSE:MRK), there's is a well-regarded dividend payer with a strong history of delivering benchmark-beating performance. In the following section, I expand a bit more on these key aspects. For those interested in digging a bit deeper into my commentary, take a look at the report on Merck here.

Advertisement

Solid track record established dividend payer

MRK delivered a triple-digit bottom-line expansion over the past couple of years, with its most recent earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 33%, which is an optimistic signal for the future.

NYSE:MRK Income Statement, August 16th 2019
NYSE:MRK Income Statement, August 16th 2019

For those seeking income streams from their portfolio, MRK is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 2.6%.

NYSE:MRK Historical Dividend Yield, August 16th 2019
NYSE:MRK Historical Dividend Yield, August 16th 2019

Next Steps:

For Merck, there are three essential factors you should further examine:

  1. Future Outlook: What are well-informed industry analysts predicting for MRK’s future growth? Take a look at our free research report of analyst consensus for MRK’s outlook.
  2. Financial Health: Are MRK’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of MRK? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NYSE:MRK

Merck

Operates as a healthcare company worldwide.

Reasonable growth potential with adequate balance sheet and pays a dividend.

Advertisement

Weekly Picks

CE
Ceazar
GOAI logo
Ceazar on Eva Live ·

This small cap is building the AI workforce of the future

Fair Value:US$7.4353.2% undervalued
71 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22043.1% undervalued
19 users have followed this narrative
6 users have commented on this narrative
21 users have liked this narrative
WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3532.8% undervalued
6 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
CA
Canderous
TAL logo
Canderous on PetroTal ·

Beyond 2026, Beyond a Double

Fair Value:CA$1.8168.5% undervalued
22 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

IV
OCI logo
Ivoed on OCI ·

OCI is not being priced on asset value. That is the opportunity.

Fair Value:€6.5643.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IV
KIN logo
Ivoed on Kinepolis Group ·

Kinepolis Group Set to Achieve 22.52% Revenue Growth Boost, Experts Dream

Fair Value:€4839.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IV
CRM logo
Ivoed on Salesforce ·

Salesforce Future Value Could Reach $263 as Market Remains Short-Sighted

Fair Value:US$26331.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.0% undervalued
114 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74018.2% undervalued
39 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$268.6116.8% undervalued
1187 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative